Literature DB >> 33574281

A genome-wide CRISPR screen identifies host factors that regulate SARS-CoV-2 entry.

Yunkai Zhu1, Fei Feng1, Gaowei Hu1, Yuyan Wang1, Yin Yu1, Yuanfei Zhu1, Wei Xu5, Xia Cai1, Zhiping Sun1, Wendong Han1, Rong Ye1, Di Qu1, Qiang Ding2, Xinxin Huang3, Hongjun Chen4, Wei Xu5, Youhua Xie1, Qiliang Cai6, Zhenghong Yuan7, Rong Zhang8.   

Abstract

The global spread of SARS-CoV-2 is posing major public health challenges. One feature of SARS-CoV-2 spike protein is the insertion of multi-basic residues at the S1/S2 subunit cleavage site. Here, we find that the virus with intact spike (Sfull) preferentially enters cells via fusion at the plasma membrane, whereas a clone (Sdel) with deletion disrupting the multi-basic S1/S2 site utilizes an endosomal entry pathway. Using Sdel as model, we perform a genome-wide CRISPR screen and identify several endosomal entry-specific regulators. Experimental validation of hits from the CRISPR screen shows that host factors regulating the surface expression of angiotensin-converting enzyme 2 (ACE2) affect entry of Sfull virus. Animal-to-animal transmission with the Sdel virus is reduced compared to Sfull in the hamster model. These findings highlight the critical role of the S1/S2 boundary of SARS-CoV-2 spike protein in modulating virus entry and transmission and provide insights into entry of coronaviruses.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33574281     DOI: 10.1038/s41467-021-21213-4

Source DB:  PubMed          Journal:  Nat Commun        ISSN: 2041-1723            Impact factor:   14.919


  44 in total

Review 1.  Sars-CoV-2: A clinical update - II.

Authors:  Mateus da Silveira Cespedes; José Carlos Rosa Pires de Souza
Journal:  Rev Assoc Med Bras (1992)       Date:  2020-04       Impact factor: 1.209

Review 2.  Coronavirus membrane fusion mechanism offers a potential target for antiviral development.

Authors:  Tiffany Tang; Miya Bidon; Javier A Jaimes; Gary R Whittaker; Susan Daniel
Journal:  Antiviral Res       Date:  2020-04-06       Impact factor: 5.970

3.  Attenuated SARS-CoV-2 variants with deletions at the S1/S2 junction.

Authors:  Siu-Ying Lau; Pui Wang; Bobo Wing-Yee Mok; Anna Jinxia Zhang; Hin Chu; Andrew Chak-Yiu Lee; Shaofeng Deng; Pin Chen; Kwok-Hung Chan; Wenjun Song; Zhiwei Chen; Kelvin Kai-Wang To; Jasper Fuk-Woo Chan; Kwok-Yung Yuen; Honglin Chen
Journal:  Emerg Microbes Infect       Date:  2020-12       Impact factor: 7.163

4.  Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia.

Authors:  Qun Li; Xuhua Guan; Peng Wu; Xiaoye Wang; Lei Zhou; Yeqing Tong; Ruiqi Ren; Kathy S M Leung; Eric H Y Lau; Jessica Y Wong; Xuesen Xing; Nijuan Xiang; Yang Wu; Chao Li; Qi Chen; Dan Li; Tian Liu; Jing Zhao; Man Liu; Wenxiao Tu; Chuding Chen; Lianmei Jin; Rui Yang; Qi Wang; Suhua Zhou; Rui Wang; Hui Liu; Yinbo Luo; Yuan Liu; Ge Shao; Huan Li; Zhongfa Tao; Yang Yang; Zhiqiang Deng; Boxi Liu; Zhitao Ma; Yanping Zhang; Guoqing Shi; Tommy T Y Lam; Joseph T Wu; George F Gao; Benjamin J Cowling; Bo Yang; Gabriel M Leung; Zijian Feng
Journal:  N Engl J Med       Date:  2020-01-29       Impact factor: 176.079

5.  Pathogenicity and transmissibility of 2019-nCoV-A quick overview and comparison with other emerging viruses.

Authors:  Jieliang Chen
Journal:  Microbes Infect       Date:  2020-02-04       Impact factor: 2.700

6.  A Multibasic Cleavage Site in the Spike Protein of SARS-CoV-2 Is Essential for Infection of Human Lung Cells.

Authors:  Markus Hoffmann; Hannah Kleine-Weber; Stefan Pöhlmann
Journal:  Mol Cell       Date:  2020-05-01       Impact factor: 17.970

7.  The role of furin cleavage site in SARS-CoV-2 spike protein-mediated membrane fusion in the presence or absence of trypsin.

Authors:  Shuai Xia; Qiaoshuai Lan; Shan Su; Xinling Wang; Wei Xu; Zezhong Liu; Yun Zhu; Qian Wang; Lu Lu; Shibo Jiang
Journal:  Signal Transduct Target Ther       Date:  2020-06-12

8.  Cell entry mechanisms of SARS-CoV-2.

Authors:  Jian Shang; Yushun Wan; Chuming Luo; Gang Ye; Qibin Geng; Ashley Auerbach; Fang Li
Journal:  Proc Natl Acad Sci U S A       Date:  2020-05-06       Impact factor: 11.205

9.  SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor.

Authors:  Markus Hoffmann; Hannah Kleine-Weber; Simon Schroeder; Nadine Krüger; Tanja Herrler; Sandra Erichsen; Tobias S Schiergens; Georg Herrler; Nai-Huei Wu; Andreas Nitsche; Marcel A Müller; Christian Drosten; Stefan Pöhlmann
Journal:  Cell       Date:  2020-03-05       Impact factor: 41.582

10.  A Unique Protease Cleavage Site Predicted in the Spike Protein of the Novel Pneumonia Coronavirus (2019-nCoV) Potentially Related to Viral Transmissibility.

Authors:  Qiong Wang; Ye Qiu; Jin-Yan Li; Zhi-Jian Zhou; Ce-Heng Liao; Xing-Yi Ge
Journal:  Virol Sin       Date:  2020-03-20       Impact factor: 4.327

View more
  67 in total

1.  Bidirectional genome-wide CRISPR screens reveal host factors regulating SARS-CoV-2, MERS-CoV and seasonal HCoVs.

Authors:  Caroline Goujon; Antoine Rebendenne; Priyanka Roy; Boris Bonaventure; Ana Chaves Valadao; Lowiese Desmarets; Yves Rouillé; Marine Tauziet; Mary Arnaud-Arnould; Donatella Giovannini; Yenarae Lee; Peter DeWeirdt; Mudra Hegde; Francisco Garcia de Gracia; Joe McKellar; Mélanie Wencker; Jean Dubuisson; Sandrine Belouzard; Olivier Moncorgé; John Doench
Journal:  Res Sq       Date:  2021-05-27

2.  The furin cleavage site in the SARS-CoV-2 spike protein is required for transmission in ferrets.

Authors:  Thomas P Peacock; Daniel H Goldhill; Jie Zhou; Laury Baillon; Rebecca Frise; Olivia C Swann; Ruthiran Kugathasan; Rebecca Penn; Jonathan C Brown; Raul Y Sanchez-David; Luca Braga; Maia Kavanagh Williamson; Jack A Hassard; Ecco Staller; Brian Hanley; Michael Osborn; Mauro Giacca; Andrew D Davidson; David A Matthews; Wendy S Barclay
Journal:  Nat Microbiol       Date:  2021-04-27       Impact factor: 17.745

3.  Bidirectional genome-wide CRISPR screens reveal host factors regulating SARS-CoV-2, MERS-CoV and seasonal HCoVs.

Authors:  Boris Bonaventure; Ana Luiza Chaves Valadão; Antoine Rebendenne; Priyanka Roy; Lowiese Desmarets; Mary Arnaud-Arnould; Yves Rouillé; Marine Tauziet; Donatella Giovannini; Jawida Touhami; Yenarae Lee; Peter DeWeirdt; Mudra Hegde; Serge Urbach; Khadija El Koulali; Francisco Garcia de Gracia; Joe McKellar; Jean Dubuisson; Mélanie Wencker; Sandrine Belouzard; Olivier Moncorgé; John G Doench; Caroline Goujon
Journal:  Nat Genet       Date:  2022-07-25       Impact factor: 41.307

4.  Lipid kinases VPS34 and PIKfyve coordinate a phosphoinositide cascade to regulate retriever-mediated recycling on endosomes.

Authors:  Sai Srinivas Panapakkam Giridharan; Guangming Luo; Pilar Rivero-Rios; Noah Steinfeld; Helene Tronchere; Amika Singla; Ezra Burstein; Daniel D Billadeau; Michael A Sutton; Lois S Weisman
Journal:  Elife       Date:  2022-01-18       Impact factor: 8.140

5.  The SARS-CoV-2 Transcriptome and the Dynamics of the S Gene Furin Cleavage Site in Primary Human Airway Epithelia.

Authors:  Wei Zou; Min Xiong; Siyuan Hao; Elizabeth Yan Zhang; Nathalie Baumlin; Michael D Kim; Matthias Salathe; Ziying Yan; Jianming Qiu
Journal:  mBio       Date:  2021-05-11       Impact factor: 7.867

Review 6.  COVID-19 one year later: a retrospect of CRISPR-Cas system in combating COVID-19.

Authors:  Yan Zhan; Xiang-Ping Li; Ji-Ye Yin
Journal:  Int J Biol Sci       Date:  2021-05-13       Impact factor: 6.580

Review 7.  Could Histamine H1 Receptor Antagonists Be Used for Treating COVID-19?

Authors:  Changbo Qu; Gwenny M Fuhler; Yihang Pan
Journal:  Int J Mol Sci       Date:  2021-05-26       Impact factor: 5.923

8.  Mutants of human ACE2 differentially promote SARS-CoV and SARS-CoV-2 spike mediated infection.

Authors:  Nidhi Shukla; Sarah M Roelle; Vinicius G Suzart; Anna M Bruchez; Kenneth A Matreyek
Journal:  PLoS Pathog       Date:  2021-07-16       Impact factor: 6.823

Review 9.  SARS-CoV-2 one year on: evidence for ongoing viral adaptation.

Authors:  Thomas P Peacock; Rebekah Penrice-Randal; Julian A Hiscox; Wendy S Barclay
Journal:  J Gen Virol       Date:  2021-04       Impact factor: 3.891

10.  Masitinib is a broad coronavirus 3CL inhibitor that blocks replication of SARS-CoV-2.

Authors:  Nir Drayman; Jennifer K DeMarco; Krysten A Jones; Saara-Anne Azizi; Heather M Froggatt; Kemin Tan; Natalia Ivanovna Maltseva; Siquan Chen; Vlad Nicolaescu; Steve Dvorkin; Kevin Furlong; Rahul S Kathayat; Mason R Firpo; Vincent Mastrodomenico; Emily A Bruce; Madaline M Schmidt; Robert Jedrzejczak; Miguel Á Muñoz-Alía; Brooke Schuster; Vishnu Nair; Kyu-Yeon Han; Amornrat O'Brien; Anastasia Tomatsidou; Bjoern Meyer; Marco Vignuzzi; Dominique Missiakas; Jason W Botten; Christopher B Brooke; Hyun Lee; Susan C Baker; Bryan C Mounce; Nicholas S Heaton; William E Severson; Kenneth E Palmer; Bryan C Dickinson; Andrzej Joachimiak; Glenn Randall; Savaş Tay
Journal:  Science       Date:  2021-07-20       Impact factor: 63.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.